                               SEQUENCE LISTING

<110> ZELARION MALTA LIMITED
 
<120> METHOD AND COMPOSITION FOR INDUCING TOLERANCE

<130> 105848PC

<140> To be assigned
<141> 2022-01-20

<150> 63/141,023
<151> 2021-01-25

<160> 9    

<170> PatentIn version 3.5

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> siplizumab VH CDR1

<400> 1
Glu Tyr Tyr Met Tyr 
1               5   


<210> 2
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> siplizumab VH CDR2

<400> 2
Arg Ile Asp Pro Glu Asp Gly Ser Ile Asp Tyr Val Glu Lys Phe Lys 
1               5                   10                  15      


Lys 
    


<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> siplizumab VH CDR3

<400> 3
Gly Lys Phe Asn Tyr Arg Phe Ala Tyr 
1               5                   


<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> siplizumab VL CDR1

<400> 4
Arg Ser Ser Gln Ser Leu Leu His Ser Ser Gly Asn Thr Tyr Leu Asn 
1               5                   10                  15      


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> siplizumab VL CDR2

<400> 5
Leu Val Ser Lys Leu Glu Ser 
1               5           


<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> siplizumab VL CDR3

<400> 6
Met Gln Phe Thr His Tyr Pro Tyr Thr 
1               5                   


<210> 7
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<223> Ab1 a Heavy chain variable region

<400> 7
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Gln Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Ile Phe Thr Glu Tyr 
            20                  25                  30          


Tyr Met Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Leu Val 
        35                  40                  45              


Gly Arg Ile Asp Pro Glu Asp Gly Ser Ile Asp Tyr Val Glu Lys Phe 
    50                  55                  60                  


Lys Lys Lys Val Thr Leu Thr Ala Asp Thr Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Lys Phe Asn Tyr Arg Phe Ala Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115    


<210> 8
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<223> Ab1 light chain variable region

<400> 8
Asp Val Val Met Thr Gln Ser Pro Pro Ser Leu Leu Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Ser Gly Asn Thr Tyr Leu Asn Trp Leu Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Pro Leu Ile Tyr Leu Val Ser Lys Leu Glu Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Gly Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Phe 
                85                  90                  95      


Thr His Tyr Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


<210> 9
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<223> Ab1 Heavy chain variable region

<400> 9
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Glu Tyr 
            20                  25                  30          


Tyr Met Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Leu Met 
        35                  40                  45              


Gly Arg Ile Asp Pro Glu Asp Gly Ser Ile Asp Tyr Val Glu Lys Phe 
    50                  55                  60                  


Lys Lys Lys Val Thr Leu Thr Ala Asp Thr Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Lys Phe Asn Tyr Arg Phe Ala Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115                        



